Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Du bruger tilsyneladende en bredere skærm. Vil du gerne give denne side en bredere visningsoplevelse?

GomSpace – Presentation of Q3 2024 interim report

Af Michael FriisHead of Equities
GomSpace Group

You can already now sign up for the event and send in your questions. You don’t have to participate live to submit questions for the event.

GomSpace is expected to release its Q3 2024 interim report on October 31, 2024. The same day at 13:00, GomSpace’s CEO Carsten Drachmann will present the results in an online live event followed by a Q&A session.

In the first half of 2024, the financial results more than supported the current transformation progress the company is going through. Order intake rose 380%, gross margin improved to 31% (-5% in 2023), and the second quarter yielded a positive cash flow. Cash flow for the first half of the year showed significant improvement with a negative of SEK 5.5m vs. the first half of 2023, which yielded a negative cash flow of SEK 70m.

In the Q3 presentation, the focus will be on GomSpace’s ongoing transformation process, whether the positive developments from the first half year have continued into Q3 and potential further details about the progress on the Maritime Domain Awareness program in Indonesia. On the last day of the third quarter, they delivered an update on the historical timeline of this program but also stated that they still await the final conclusion.

In connection with that update, the company reiterated its 2024 guidance of positive free cash flow in the second half of 2024 and stated that revenue is expected to surpass the 2023 level.

Disclaimer: HC Andersen Capital receives payment from GomSpace for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis, 11.15, 1 October 2024.

Seneste videoer

Herantis Pharma Plc, Phase 1b biomarker data webcast
08.01.2026, 11.00 Herantis Pharma
HCA Morgenbørs 08/01 - Røde futures og fokus på kursmålsjusteringer
08.01.2026, 09.18 Novo Nordisk
HCA Morgenbørs 07/01 - Vi ser ind i en blandet udvikling på de globale futures-markeder med Europa i plus og USA i minus
07.01.2026, 09.58 RTX
Roblon – Præsentation af årsregnskabet for 2024/25
06.01.2026, 10.00 Roblon
HCA Morgenbørs 06/01 - Europæiske futures indikerer at vi forlænger Santa Claus rally'et
06.01.2026, 09.18 Novo Nordisk
Vis alle videoer
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.